Actinomycin, discovered by Waksman and Woodruff in 1940,1 was the first antibiotic to be isolated in crystalline form from a culture of an actinomycete (Streptomyces antibioticus). Waksman et al.' found that it was a red-pigmented substance, highly active against Gram-positive bacteria and, to a lesser degree, Gram-negative organisms; it proved to be extremely toxic to experimental animals. Waksman and Tishler' reported that actinomycin was optically active ([a]22, = -3200 i 50), possessing a molecular weight of about 768-1,000, and gave a melting point of 250°C. It exhibited characteristic absorption in the visible (450 mMA) and ultraviolet (between 230 and 250 muA) regions. On the basis of the analytical data, an approximate empirical formula, C41H5601,N9, was suggested. Actinomycin was thought to be a polycyclic nitrogen compound, possessing a quinonoid system. Initially, it was believed that actinomycin represented two active substances, which were designated A and B. Subsequently it was discovered that the B fraction consisted of lipoidal material contaminated with small quantities of A, and the recognition of an actinomycin B was dropped. The homogeneity of actinomycin A was based on the constant optical rotation and absorption spectra obtained when preparations of the antibiotic were crystallized repeatedly from acetone and from ethyl acetate.